Menéndez BotetC.J., NisselbaumJ.S., FleisherM.Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue.Clin Chem1976; 22: 1366–71.
2.
OhuchiN., PageD., MerinoM.J., ViglioneM.F., KufeD., SchlomJ.Expression of tumor-associated' antigen (DF3) in atypical hyperplasias and in situ carcinomas of the breast.J Natl Cancer Inst1987; 79: 109–17.
3.
KufeD., InghiramiG., AbeM., HayesD., Justi-WheelerH., SchlomJ.Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.Hybridoma1984; 3: 223–32.
4.
MiyaT., WatanabeT., AdachiI.Analysis of cytosol CA15.3, carcinoembryonic antigen, estrogen and progesterone receptors in breast tissues.Jpn J Cancer Res1992; 83: 171–7.
5.
SuarezB., GonzálezC., AllendeMaTCAM26 and CAM29 cytosol levels in breast tumors classified according to estrogen receptor status. First results.Int J Biol Markers1992; 7: 126–8.
6.
BrownA.M.C., JeltsehJ.M., RobertsM., ChambonP.Activation of pS2 gene transcription is a primary response to estrogen in the breast cancer cell line MCF-7.Proc Natl Acad Sci USA1984; 81: 6344–8.
7.
RioM.C., BellocqJ.P., GairadB.Specific expression of the pS2 gene in subclasses of breast cancer in comparison with expression of the estrogen and progesterone receptors and the oncogen erbB2.Proc Natl Acad Sci USA1987; 84: 9243–7.
8.
HenryJ.A., BennettM.K., PiggottN.H., LevettD.L., MayF.E.B., WestleyB.R.Expression of the pNR/pS2 protein in diverse human epithelial tumors.Br J Cancer1991; 64: 677–82.
9.
WysockiS.J., HahnelE., MastersA., SmithV., McCartneyA.J., HahnelR.Detection of pS2 messenger RNA in gynecological cancers.Cancer Res1990; 50: 1800–2.
10.
PredineJ., SpyratosF., Prud hommeJ.F.Enzym-elinked immunosorbent assay of pS2 in breast cancer, benign tumors, and normal breast tissues.Cancer Res1992; 69: 2116–23.
11.
FoekensJ.A., RioM.C., SeguinP.Prediction of relapse and survival in breast cancer patients by pS2 protein status.Cancer Res1990; 50: 3832–7.
